Valeur20212022202320242025Total du passif12.34 M19.08 M46.41 M60.7 M107.77 MTotal des capitaux propres151.66 M150.92 M78.13 M241.45 M332.33 MTotal du passif et des capitaux propres164 M169.99 M124.54 M302.15 M440.1 MDette totale——14.13 M21.85 M40.58 MDette nette——14.13 M21.85 M-371.01 M
Definium Therapeutics, Inc. - Common Shares
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs.